Serial Number | 98414633 |
Word Mark | EVEREST MEDICINES |
Filing Date | Wednesday, February 21, 2024 |
Status | 641 - NON-FINAL ACTION - MAILED |
Status Date | Wednesday, September 11, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Description of Mark | The mark consists of the words "EVEREST MEDICINES" in stylized font with stylized symbol for mountains above. |
Goods and Services | Pharmaceuticals, namely, pharmaceutical preparations for treating diseases and conditions in the field of oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, gastrointestinal or women's health; Pharmaceutical research; Pharmaceutical drugs, namely, pharmaceutical preparations for oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, gastrointestinal or women's health; Pharmaceutical preparations for health care, namely, for oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, gastrointestinal or women's health; Pharmaceutical preparations for oral, intravenous, topical, parenteral, rectal or sublingual use in connection with humans for oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, gastrointestinal or women's health |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Goods and Services | Active chemical ingredients for use in the manufacture of anti-cancer drugs; Chemical additives for use in the manufacture of medicines; Chemical substances for use in the production of drugs |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, February 21, 2024 |
Primary Code | 001 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, February 21, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Everest Medicines (Singapore) Pte. Ltd. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 24 - NOT AVAILABLE |
Address | Singapore 049712 SG |
Event Date | Event Description |
Wednesday, February 21, 2024 | NEW APPLICATION ENTERED |
Sunday, June 30, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Sunday, June 30, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, September 11, 2024 | NON-FINAL ACTION WRITTEN |
Wednesday, September 11, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Thursday, October 24, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Thursday, October 24, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Thursday, October 24, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Wednesday, September 11, 2024 | NON-FINAL ACTION E-MAILED |
Wednesday, September 11, 2024 | ASSIGNED TO EXAMINER |